Open AccessChemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing
Author(s) -
Wanqing Iris Zhi,
Patricia Chen,
Alice Kwon,
Connie Chen,
Steven E. Harte,
Lauren Piulson,
Susan Li,
Sujata Patil,
Jun J. Mao,
Ting Bao
Publication year - 2019
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-019-05416-4
Subject(s) - chemotherapy induced peripheral neuropathy , medicine , breast cancer , rating scale , peripheral neuropathy , quantitative sensory testing , physical therapy , neuropathic pain , gynecologic oncology , cancer , physical medicine and rehabilitation , sensory system , anesthesia , psychology , developmental psychology , endocrinology , cognitive psychology , diabetes mellitus
CIPN is a common, debilitating, and dose-limiting side effect of chemotherapy. Here, we describe characteristics of patients with CIPN using both patient-reported outcomes (PRO) and quantitative sensory testing (QST).